Khiron Life Sciences Corp. reported the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration Chief of Pharmaceutical Investigations, to the Advisory Board of the Company. Mr. Murphy will support the Company by advising on the implementation of closed loop systems to prevent product diversion and to enhance protocols across Khiron's plant to patient value chain.